Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Retrospective Study to Develop and Validate the CTA-Derived DIEP Morphological Deviation Score (DIEP-MDS) for Risk Stratification of Flap-Related Vascular Compromise and Flap Failure After DIEP Flap Breast Reconstruction

NCT07761390 is registered in ClinicalTrials.gov with Zhuliling as lead sponsor.

NCT NCT07761390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07761390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Retrospective Study to Develop and Validate the CTA-Derived DIEP Morphological Deviation Score (DIEP-MDS) for Risk Stratification of Flap-Related Vascular Compromise and Flap Failure After DIEP Flap Breast Reconstruction
Lead sponsor
Zhuliling
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2026
Completion date
December 31, 2026
Enrollment
1,500 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, breast reconstruction, postoperative complications